Pyridine → 2-Chloro-N-(2,6-dimethoxypyridin-4-yl)pyridine-3-sulfonamide
반응식
[Cl:1][C:2]1[C:7]([S:8](Cl)(=[O:10])=[O:9])=[CH:6][CH:5]=[CH:4][N:3]=1.[CH3:12][O:13][C:14]1[CH:19]=[C:18]([NH2:20])[CH:17]=[C:16]([O:21][CH3:22])[N:15]=1.N1C=CC=CC=1>C(Cl)Cl>[Cl:1][C:2]1[C:7]([S:8]([NH:20][C:18]2[CH:17]=[C:16]([O:21][CH3:22])[N:15]=[C:14]([O:13][CH3:12])[CH:19]=2)(=[O:10])=[O:9])=[CH:6][CH:5]=[CH:4][N:3]=1참가 물질
5
실험 절차
The title compound (623 mg, 1.89 mmol) was prepared from 2-chloropyridine-3-sulfonyl chloride (530 mg, 2.5 mmol), 2,6-dimethoxy-4-pyridinamine (424 mg, 2.8 mmol) and pyridine (0.6 mL, 7.5 mmol) in DCM (10 mL) using the methods of (IntC1).
출처 및 근거
- ORD 기록
- ord-6ececb050c4a455b8720ef3382e70e88
- 출처 데이터셋
- uspto-grants-2016_02
- 특허 번호
- US09249160B2
반응 노트
불러오는 중…